PRTA Margin resik Prothena Corporation

Simbol lan logo merek Prothena Biosciences (PRTA)

High risks of clinical trial failure and regulatory pressure are creating volatility for Prothena Corporation (PRTA). However, the development of protein pathology therapies for the neurodegeneration market expands its potential. Anticipation of Phase 3 data for AL amyloidosis is driving the momentum, where the company's net margin ratio on this GURU.Markets chart demonstrates resilience, and -45.40 reflects the metric's baseline.

Tingkat bathi resik Prothena Corporation (PRTA): kanggo periode 04.07.2022 - 19.11.2026

Rincian analitis perusahaan Prothena Corporation

- rega saham lan prakiraan rega para ahli:
Ringkesan analitik perusahaan:Prothena Corporation - PRTA
Produk asil prodhuksi Prothena Corporation PLC

Patent protection for antibodies used in the therapy of neurodegenerative diseases provides Prothena Corporation (PRTA) with an exclusive market advantage under strict FDA oversight. An analysis of financial sales margins allows for an assessment of the net profit share of revenue, revealing the gap between turnover growth and final profitability, which is critical for evaluating the fair value of shares and avoiding the purchase of overvalued assets.

Analisis pesaing

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|alector.com (ALEC) - Margin resik|ANNX: Rentabilitas dodolan miturut bathi resik|Margin resik Omeros|NGNE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik AC Immune|Rentabilitas dodolan miturut bathi resik VYGR|Rentabilitas dodolan resik NMRA (neumoratx.com)|Rentabilitas dodolan miturut bathi resik SCLX (Scilex Holding Company, Inc.)|Margin resik TVGN (Tevogen Bio)|Margin resik Alpha Cognition ACOG|CGTX - Rentabilitas dodolan miturut bathi resik|IKT - Margin resik|SAVA: Margin resik|Assertio Therapeutics (ASRT) - Margin resik|Margin resik Coya Therapeutics Inc (COYA)|Margin resik Vistagen|Rentabilitas dodolan resik OVID (ovidrx.com)|Margin resik Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Margin resik|Alterity Therapeutics Ltd. - Rentabilitas dodolan miturut bathi resik|CLNN - Rentabilitas dodolan miturut bathi resik|PEPG - Margin resik|Margin dodolan perusahaan jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Margin resik|ANVS (Annovis Bio, Inc.) - Margin resik|Margin resik gracetx.com|Margin dodolan resik Firefly Neuroscience, Inc.|Margin resik ANEW Medical (KLTO)|NRSN - Margin resik|Margin dodolan resik RVPH (Reviva Pharmaceuticals Holdings Inc.)|Rentabilitas resik perusahaan MTVA (metaviatx.com)|NeurAxis Inc. - Margin dodolan resik|Margin dodolan perusahaan heliusmedical.com HSDT|PASG: Margin dodolan resik|Neuphoria - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik NERV|ATHA: Tingkat bathi resik|Margin resik Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Tingkat bathi resik|Margin dodolan resik CYCN (cyclerion.com)|Tingkat bathi miturut bathi resik Protagenic|KTTA: Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik CRGT (cortigent.com)|ATXI: Margin dodolan resik|BCLI (BrainStorm Cell Therapeutics) - Margin resik|CARA (Cara Therapeutics Inc.) - Margin dodolan resik|Margin resik CHRO|Rentabilitas dodolan miturut bathi resik ELYM (Eliem Therapeutics)|Margin resik ITCI (Intra-Cellular Therapies Inc.)|Margin dodolan resik LBPH (Longboard Pharma)|Margin dodolan resik Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Margin dodolan resik|Tingkat bathi resik NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel